Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Atea Pharmaceuticals, Inc. Common Stock (AVIR)

Pharmaceutical Preparations

https://www.ateapharma.com

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

225 FRANKLIN STREET, SUITE 2100
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/30/2020

Market Cap

312,783,510

Shares Outstanding

83,440,000

Weighted SO

83,435,513

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

IMMX --.--%

CNSP --.--%

HEPA --.--%

FRLN --.--%

AVRO --.--%

ENVB --.--%

CWBR --.--%

ELEV --.--%

OCEA --.--%

Beta

0.1740

Last Div

0.0000

Range

2.765-4.6

Chg

-0.0350

Avg Vol

249095

Mkt Cap

312783510

Exch

NASDAQ

Country

US

Phone

857 284 8891

DCF Diff

2.0441

DCF

1.6959

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.3506

P/FV

0.6552

Div Yield %

0.0000

P/E

-1.7737

PEG

0.1027

Payout

0.0000

Current Ratio

19.0228

Quick Ratio

19.0228

Cash Ratio

9.1436

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

4799.3990

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0060

ROA

-0.3448

ROE

-0.3324

ROCE

-0.4219

NI/EBT

1.0060

EBT/EBIT

0.8573

EBIT/Rev

0.0000

Debt Ratio

0.0040

D/E

0.0043

LT Debt/Cap

0.0026

Total Debt/Cap

0.0042

Int Coverage

0.0000

CF/Debt

-59.9960

Equity Multi

1.0712

Rec Turnover

0.0000

Pay Turnover

0.0761

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-1.4420

FCF/Share

-1.4420

Cash/Share

5.9607

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

-59.9960

ST Coverage

-155.7590

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.6552

P/B

0.6552

P/S

0.0000

P/E

-1.7737

P/FCF

-2.5745

P/OCF

-2.5694

P/CF

-2.5694

PEG

0.1027

P/S

0.0000

EV Multiple

-0.3506

P/FV

0.6552

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Mar 21, 21:54 Atea Pharmaceuticals Issues Statement Regarding Director Nominations Benzinga Jan 09, 13:33 Atea Pharmaceuticals' Hepatitis C Virus Candidate Shows Efficacy

Revenue Product Segmentation